Which is better for thin endometrium normal PRP or subendometrial PRP
Reading File
Searching PubMed
"platelet-rich plasma" AND "thin endometrium" AND subendometrial
Searching PubMed
"platelet-rich plasma" AND "thin endometrium" AND intrauterine infusion
Finding Sources
Reading Article
PMID: 41286777
Reading Article
PMID: 41700009
Reading Article
PMID: 38792379
Reading Article
PMID: 40098101
I now have excellent data from a direct head-to-head systematic review + meta-analysis and several primary studies. Let me compile the full answer.
Subendometrial PRP vs. Normal (Intrauterine) PRP Infusion for Thin Endometrium
What are the two methods?
| Feature | Intrauterine Infusion (Normal PRP) | Subendometrial Injection |
|---|---|---|
| Route | Catheter into uterine cavity (like IUI) | Direct injection into subendometrial layer (junctional zone) via ultrasound-guided transvaginal route OR hysteroscopy |
| Depth of delivery | Endometrial surface / cavity | Into or just beneath the basal endometrium |
| Technique complexity | Simple, outpatient, no anesthesia | Requires ultrasound guidance or hysteroscope; more technically demanding |
| Growth factor reach | Diffuses from lumen inward | Delivered directly to the proliferative basal layer |
What does the evidence say?
1. Systematic Review + Meta-Analysis (Kumar et al., 2025 - highest level evidence)
Kumar et al., Reprod Biol Endocrinol 2025 directly compared subendometrial injection vs. placebo or intracavity infusion:
- Clinical Pregnancy Rate (CPR): Subendometrial injection vs. placebo - OR = 5.14 (p < 0.001)
- Live Birth Rate (LBR): OR = 4.60 (p < 0.001)
- Miscarriage Rate: Reduced - OR = 0.60 (p = 0.036)
- Injection vs. infusion in resistant thin endometrium: Injection showed significantly higher CPR benefit (p = 0.03)
Conclusion from this meta-analysis: "Sub-endometrial administration may improve the efficacy of PRP in selected patients" - but authors note the benefit over infusion was most apparent in resistant/refractory thin endometrium, and whether injection should be first-line vs. after failed infusion remains debated.
2. Prospective Case-Control Study (Yu et al., 2024)
Yu et al., J Clin Med 2024 compared 55 intrauterine infusion vs. 38 hysteroscopic injection vs. 23 controls:
- Endometrial thickness >7 mm achieved in: 78.2% (infusion) vs. 55.3% (injection)
- However, implantation rate: 52% (injection) vs. control 18%
- CPR: 52% (injection) vs. 22% (control)
- Live birth rate: 38% (injection) vs. 4% (control)
- Infusion group outcomes were intermediate but the injection group showed superior pregnancy outcomes despite lower rate of thickness normalization
Key finding: Infusion was better at increasing thickness, but injection produced better pregnancy outcomes - suggesting that subendometrial delivery improves endometrial receptivity beyond just thickness.
3. Prospective Cohort - Subendometrial US-Guided Injection (Cakiroglu et al., 2025)
Cakiroglu et al., BMC Pregnancy Childbirth 2025 in 200 women with refractory thin endometrium:
- Endometrial thickness: 7.7 ± 1.9 mm (PRP) vs. 6.1 ± 1.2 mm (control)
- Clinical pregnancy rate: 22.7% vs. 7.0% (p = 0.002)
- Live birth rate: 17.5% vs. 2.0% (p < 0.001)
4. 2026 Systematic Review (Tan et al., 2026)
Tan et al., Turk J Obstet Gynecol 2026 (14 studies, 523 patients) confirmed PRP significantly increases endometrial thickness (mean difference +1.61 mm, 95% CI: 1.21-2.01) with a pooled CPR of 41.5%.
The Bottom Line: Which is Better?
| Outcome | Intrauterine Infusion | Subendometrial Injection |
|---|---|---|
| Ease of procedure | Easier (outpatient, no anesthesia) | More complex (USG/hysteroscopy guided) |
| Endometrial thickness gain | Good | Slightly less, but still significant |
| Pregnancy outcomes (CPR, LBR) | Moderate improvement | Superior, especially in refractory cases |
| Miscarriage reduction | Less data | Significantly reduced (OR 0.60) |
| Best candidate | First-line, less severe cases | Refractory/resistant thin endometrium |
Practical recommendation based on current evidence:
- Start with intrauterine infusion (normal PRP) for most patients - it is simpler, well-tolerated, and produces meaningful improvements in endometrial thickness and pregnancy rates.
- Escalate to subendometrial injection for patients who have failed or are resistant to standard infusion ("refractory thin endometrium"). The evidence for superior pregnancy outcomes with injection is strongest in this group.
- The biologic rationale for subendometrial injection is sound: delivering PRP growth factors (VEGF, EGF, PDGF, IGF-1, TGF-β) directly to the basal endometrium and junctional zone targets the stem/progenitor cells responsible for endometrial regeneration.
Caveat: The overall evidence base is still limited in size and methodological quality. No large, well-powered RCT has directly randomized patients to infusion vs. injection head-to-head. The 2024 Cochrane Review on PRP for assisted reproduction (PMID 38682756) notes that high-quality RCT data are still needed. These findings should be interpreted with appropriate caution, and patient-specific factors (anatomy, cause of thin endometrium, prior treatments) should guide clinical decisions.
This is a shared conversation. Sign in to Orris to start your own chat.